Toggle sidebar
定价
登录
Medications for severe endocrinologic
搜索文档
Corcept Announces Planned Leadership Transition
Businesswire
·
2026-09-23 20:00
管理层变动 - Corcept Therapeutics公司内分泌部门总裁Sean Maduck退休 [1] - Justin Gunn将接替Sean Maduck的职位,并于10月起全面承担新职责 [1]
cept Therapeutics rporated(US:CORT)
Biotechnology
Medications for severe endocrinologic
oncologic
metabolic and neurologic disorders
Biotechnology
Medications for severe endocrinologic
oncologic
metabolic and neurologic disorders